David Berz, Frans Opdam, Daniela Maier, Kerstin Moeldner, Martin Augsten, Anke Baum, Irene C. Waizenegger, Behbood Sadrolhefazi, John Heymach, Noboru Yamamoto, Minal A. Barve. "Zongertinib in HER2-altered breast cancer: Preclinical activity and preliminary results from a phase Ia dose-escalation study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1023